PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal - “Cradle to cradle” approach addresses every stage of a product’s lifecycle (NYSE:BDX)
BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal

 

NewswireToday - /newswire/ - Franklin Lakes, NJ, United States, 2011/01/24 - “Cradle to cradle” approach addresses every stage of a product’s lifecycle (NYSE:BDX). NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BD (Becton, Dickinson and Company), a leading global medical technology company, and Rady Children’s Hospital-San Diego today announced that they have implemented an innovative pilot program at the Hospital that is designed to safely divert a significant percentage of BD sharps waste from landfills and utilize the recycled materials.

Single-use, disposable medical devices such as needles and syringes provide clear clinical and public health benefits, including protecting patients and healthcare workers from the spread of infections. However, disposal of these devices may create unintended environmental concerns, and unnecessary costs. BD is committed to seeking innovative sustainability solutions to address the environmental impact of disposal without compromising patient care. One approach BD is exploring to manage its disposable medical device products is a comprehensive “cradle to cradle” program, addressing every stage of a product’s lifecycle. This entails recycling waste materials and utilizing them to manufacture new products rather than permanently disposing of them in a landfill.

“The connections between human health and a healthy environment are inseparable. BD is committed to reducing our environmental impacts and supporting our customers and suppliers to do the same, ” said Bill Kozy, Executive Vice President, BD. “Rady Children’s Hospital shares our commitment to sustainability, and we commend it for its leadership in participating in this important pilot program.”

“This environmentally-friendly solution to disposing of sharps wastes falls perfectly in line with our hospital initiatives to reduce, reuse and recycle, ” said Randy Veenstra, Green Team leader at Rady Children’s. “We estimate that, thanks to this program, 38,000 pounds of sharps waste that might have been sent to a landfill will be recycled.”

Based on initial tests, BD believes that more than 70% of its overall sharps waste may ultimately be recovered and recycled for use in new products. This novel pilot program, developed in collaboration with Waste Management (WM), the largest waste management and recycling company in North America, uses BD Sharps Containers as natural, convenient aggregation points for the collection of sharps waste. Waste Management collects filled sharps containers at the hospital, transports the material to a nearby WM facility, safely treats it to eliminate any potential biohazard and sends it to a local recycling company for raw material recovery. BD then incorporates these post-hospital recycled materials, along with recycled materials from other sources, into the making of new BD Recykleen™ container products. BD plans to sell excess recycled materials that cannot be used in BD products to other recyclers.

This product stewardship program builds upon BD's sustainability commitment, which has been recognized for achievements in environmental stewardship. In Newsweek’s 2010 “Green Rankings” of the 500 largest U.S. corporations, BD ranked 2nd in the Healthcare sector and 24th overall. Additionally, BD has been a component of the Dow Jones Sustainability World Index (DJSI World) and DJSI North America for five and six consecutive years, respectively. Inclusion in DJSI World puts BD in the top 10 percent of companies in the healthcare sector assessed for sustainability leadership. BD was one of only ten organizations nationwide to receive a 2010 Leadership Award from the U.S. Environmental Protection Agency in the Green Power Purchase category. BD's worldwide headquarters in Franklin Lakes, NJ, and three of the Company's U.S. manufacturing sites are offsetting 100 percent of their electricity use with renewable energy through green power purchases and renewable energy credits (RECs), placing BD at #20 on the U.S. EPA Green Power Partnership's National Top 50 list.

To learn more about BD’s commitment to environmental stewardship, please visit bd.com/sustainability.

About BD
BD (bd.com), a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

About Rady Children’s Hospital-San Diego
Rady Children's Hospital-San Diego (rchsd.org), the largest children’s hospital in California, is a 442-bed pediatric care facility providing the largest source of comprehensive pediatric medical services in San Diego, Southern Riverside and Imperial counties. Rady Children’s is the only hospital in the San Diego area dedicated exclusively to pediatric healthcare and is the region’s only designated pediatric trauma center. On October 10, 2010, Rady Children's opened the Acute Care Pavilion, a LEED-Certified (green) building that is home to the incredible new Peckham Center for Cancer and Blood Disorders, the state-of-the-art Warren Family Surgical Center, and a Neonatal Intensive Care Unit that cares for our community’s most fragile newborns. In 2001, Rady Children’s formed an affiliation agreement with the University of California-San Diego to unify pediatric patient care, research, education, and community service programs on the Rady Children’s campus. In August 2010, U.S. News & World Report ranked Rady Children’s among the nation’s best in five pediatric specialties.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

BD | Rady Children’s Hospital
Publisher Contact: Colleen T. White - BD.com 
201-847-5369 colleen_white[.]bd.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Becton, Dickinson and Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)